Plasmacytic myeloma.  A study of the relationship of survival to various clinical manifestations and anomalous protein type in 112 patients.
D000328:Adult; D000368:Aged; D001536:Bence Jones Protein / Q000097:blood* / Q000652:urine; D001798:Blood Proteins / Q000032:analysis*; D001806:Blood Urea Nitrogen; D002118:Calcium / Q000097:blood; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006452:Hemoglobinometry; D006801:Humans; D007122:Immunoelectrophoresis; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy / Q000401:mortality
D001798:Blood Proteins; D003520:Cyclophosphamide; D001536:Bence Jones Protein; D008558:Melphalan; D002118:Calcium